Hsa-miR-181a-5p, hsa-miR-182-5p, and hsa-miR-26a-5p as potential biomarkers for BCR-ABL1 among adult chronic myeloid leukemia treated with tyrosine kinase inhibitors at the molecular response
Article in BMC Cancer (March 2022)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in BMC Cancer (March 2022)
Article in Case Reports in Hematology (November 2018)